Harbour Investments’s Twist Bioscience TWST Stock Holding History

Harbour Investments’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$717	Sell	7 -7	-50%	-$455	﹤0.01%	4296
2026 Q1	$669	Buy	+14	New	+$628	﹤0.01%	4196
2025 Q4	–	Sell	-72	Closed	-$2.03K	–	4017
2025 Q3	$2.03K	Buy	+72	New	+$2.18K	﹤0.01%	3266
2023 Q3	–	Sell	-40	Closed	-$818	–	3103
2023 Q2	$818	Buy	40 +17	+74%	+$255	﹤0.01%	2732
2023 Q1	$347	Buy	23 +2	+10%	+$44	﹤0.01%	2841
2022 Q4	$500	Buy	+21	New	+$609	﹤0.01%	2793
2021 Q4	–	Sell	-89	Closed	-$10K	–	3625
2021 Q3	$10K	Buy	89 +6	+7%	+$687	﹤0.01%	2687
2021 Q2	$11K	Buy	83 +40	+93%	+$4.65K	﹤0.01%	2683
2021 Q1	$5K	Buy	+43	New	+$6.53K	﹤0.01%	2938

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Harbour Investments's TWST Position: Q2 2026 in Review

Harbour Investments reduced its Twist Bioscience (TWST) stake by 50% in Q2 2026, selling an estimated $455 and leaving 7 shares worth $717. The position accounts for ﹤0.01% of the portfolio, ranked #4296.

Harbour Investments first reported a position in TWST in Q1 2021 and has held it in 9 quarters since. The position peaked at $11K in Q2 2021. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Harbour Investments held 7 shares of Twist Bioscience worth $717 as of Q2 2026.
Harbour Investments sold 7 Twist Bioscience shares in Q2 2026, an estimated $455.
Twist Bioscience made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4296 holding.
Harbour Investments first reported a position in Twist Bioscience in Q1 2021 and has held it in 9 quarters since.
Harbour Investments's Twist Bioscience position peaked at $11K in Q2 2021.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.